Filing Details
- Accession Number:
- 0001371285-22-000224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-03 21:17:20
- Reporting Period:
- 2022-09-28
- Accepted Time:
- 2022-10-03 21:17:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1611679 | Darryl Rawlings | C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 400 Seattle WA 98108 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-09-28 | 4,000 | $0.00 | 565,043 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2022-09-28 | 4,000 | $0.00 | 861,109 | No | 5 | G | Indirect | By Kuyashii Primary Equities LLC |
Common Stock | Disposition | 2022-09-30 | 4,000 | $61.38 | 857,109 | No | 4 | S | Indirect | By Kuyashii Primary Equities LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Indirect | By Kuyashii Primary Equities LLC |
No | 4 | S | Indirect | By Kuyashii Primary Equities LLC |
Footnotes
- Represents transfer of shares from reporting person to Kuyashii Primary Equities, LLC, a limited liability company, indirectly, wholly-owned by the reporting person and reporting person's spouse.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.41 to $62.97 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)